Clivia Pharma Private Limited

Clivia Pharma Private Limited - pharma in Palarivattom, Kerala, India. FY 2026 financials & compliance.
CIN U51397KL2010PTC026644 Incorporated 01 September 2010 ROC Ernakulam HQ Palarivattom, Kerala, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹6.83 Cr
▲ 50% YoY
Net profit · FY 2025
₹18.67 Lakh
Net margin 2.7%
EBITDA · FY 2025
₹41.74 Lakh
EBITDA margin 6.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹2.25 Cr
Satisfied ₹2 Cr
Company age
16 yrs
Est. 2010
Directors on board
5
As per MCA filings

About Clivia Pharma Private Limited

Data last updated:

Clivia Pharma Private Limited is a private limited company based in Palarivattom, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 September 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2010PTC026644. Its GSTIN is 32AAECC2292H1ZX (Kerala).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vasudevan Santhosh (Managing Director) and Kizhakkiveettil Manojkumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 40/869 – B(1) B(2) North Janatha Road Palarivattom Ernakulam – 682025, Kerala, India – 682025.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.83 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹18.67 Lakh (net margin 2.7%) and EBITDA of ₹41.74 Lakh (EBITDA margin 6.1%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 37% over five years.

As per MCA filings, the company has open charges of ₹2.25 Cr and satisfied charges of ₹2 Cr on record.

Clivia Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0025903). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51397KL2010PTC026644
Registration Number 026644
Incorporation Date 01 September 2010
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-02-0025903

Recognitions & Rankings of Clivia Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-KL-02-0025903

Contact details

Clivia Pharma Private Limited's registered office is in Palarivattom, Kerala. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    40/869 – B(1) B(2) North Janatha Road Palarivattom Ernakulam – 682025, Kerala, India – 682025
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Clivia Pharma Private Limited, buy the company report.

Comprehensive company report
Clivia Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Clivia Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Clivia Pharma Private Limited, buy the company report.

Financials of Clivia Pharma Private Limited

FY 2025 filings available

Clivia Pharma Private Limited reported revenue of ₹6.83 Cr (up 50% YoY) for FY 2025.

Revenue · FY 2025
₹6.83 Cr ▲ 50%
Net profit · FY 2025
₹18.67 Lakh margin 2.7%
EBITDA · FY 2025
₹41.74 Lakh margin 6.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 50%
3 years · compounded
▲ 38%
5 years · compounded
▲ 37%
EBITDA CAGR growth
1 year
▲ 110%
3 years · compounded
▲ 23%
5 years · compounded
▲ 34%

Revenue has grown at a compounded annual rate (CAGR) of 37% over five years, including 50% growth in the latest year. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹41.74 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹18.67 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.1%
Net Profit Margin2.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Clivia Pharma Private Limited, buy the company report.

Board of directors of Clivia Pharma Private Limited

Clivia Pharma has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kizhakkiveettil ManojkumarDirector03 May 20179 Years 5 MonthsCurrent
Benny PanakkalDirector01 Aug 20197 Years 2 MonthsCurrent
Pradeep PengattuDirector01 Aug 20197 Years 2 MonthsCurrent
Vasudevan SanthoshManaging Director01 Aug 20197 Years 2 MonthsCurrent
Alwin GeorgeDirector01 Aug 20197 Years 2 MonthsCurrent

Peer comparison

Clivia Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Tenatra Exports Private Limited₹6.88 Cr (FY 2025)21.0%Mumbai, Maharashtra, India
Achyut Healthcare Limited₹6.86 Cr (FY 2024)109.0%Ahmedabad, Gujarat, India
Aktis Pharma India Private Limited₹6.85 Cr (FY 2025)12.0%Hyderabad, Telangana, India
Bhairav Health and Wellness Private Limited₹6.83 Cr (FY 2020)13.0%Panvel, Maharashtra, India
Clivia Pharma Private Limitedthis company₹6.83 Cr (FY 2025)₹18.67 Lakh2.7%50.0%Palarivattom, Kerala, India
Nirkm Healthcare Private Limited₹6.83 Cr (FY 2025)0.0%Ernakulam, Kerala, India
Chandravim Exim Private Limited₹6.81 Cr (FY 2025)-38.0%Mumbai, Maharashtra, India

To see the full peer comparison of Clivia Pharma Private Limited, buy the company report.

Auditor

Clivia Pharma Private Limited is audited by Meenakshi Rajkumar for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Meenakshi RajkumarFY 2023252405

Shareholding

The shareholding of Clivia Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Clivia Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2.25 Cr
Satisfied charges
₹2 Cr
Breakdown by lending institutions
State Bank of India₹2.25 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
13 Aug 2025101181901State Bank of India₹2.25 CrOpen
29 Jul 2023100774334Others₹2 CrSatisfied

To see the full charge records of Clivia Pharma Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Clivia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Clivia Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AAECC2292H1ZXKeralaActive01 Jul 2017

To see the full GST registrations and return filing status of Clivia Pharma Private Limited, buy the company report.

Recent activity

Clivia Pharma Private Limited has 11 board changes on record since 2017: 5 appointments and 6 cessations. The latest: Kizhakkiveettil Manojkumar ceased to be Managing Director on 01 Apr 2021.

AGM
Clivia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 29 Jul 2023 via Charge ID 100774334 with Others was fully satisfied on 10 Sep 2025.
Charges
A charge with State Bank Of India amounted to Rs. 225.00 Lakh with Charge ID 101181901 was registered on 13 Aug 2025.
Filing
Clivia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge with Others of Rs. 200.00 Lakh registered on 29 Jul 2023 with Charge ID 100774334 was modified on 16 Aug 2024.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100774334 was registered on 29 Jul 2023.
Ceased
Kizhakkiveettil Manojkumar ceased to be Managing Director.
Ceased
Vasudevan Santhosh ceased to be Director.
Appointed
Alwin George was appointed as Director.
Ceased
Ayyappath Sankarankutty Priya ceased to be Whole-Time Director.
Appointed
Benny Panakkal was appointed as Director.
Appointed
Pradeep Pengattu was appointed as Director.

6 earlier events are in the company report.

Frequently asked questions

Clivia Pharma is an active private limited company based in Palarivattom, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 September 2010 (16+ years old) and is registered under CIN U51397KL2010PTC026644.

Clivia Pharma has 5 current directors:

The latest financial statements of Clivia Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Clivia Pharma is 32AAECC2292H1ZX, registered in Kerala.

The CIN (Corporate Identification Number) of Clivia Pharma is U51397KL2010PTC026644. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Clivia Pharma was incorporated on 01 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ernakulam.

The peers of Clivia Pharma by revenue are Tenatra Exports Private Limited, Achyut Healthcare Limited, Aktis Pharma India Private Limited, Bhairav Health and Wellness Private Limited, Nirkm Healthcare Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Kizhakkiveettil Manojkumar ceased to be Managing Director on 01 Apr 2021. Vasudevan Santhosh ceased to be Director on 01 Apr 2021. Alwin George was appointed as Director on 01 Aug 2019. Clivia Pharma has 11 board changes on record in total.

Yes, Clivia Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-02-0025903).

The registered office of Clivia Pharma is at 40869 – B1 B2 North Janatha Road Palarivattom Ernakulam – 682025, Kerala, India – 682025.

Clivia Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.